We are live on ! Find out more
AP

Arlington Partners Portfolio holdings

AUM $55.4M
1-Year Est. Return 8%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+8%
3 Year Est. Return
+43.69%
5 Year Est. Return
+33.63%
10 Year Est. Return
–
AUM
$289M
AUM Growth
+$18.3M
Cap. Flow
+$11.8M
Cap. Flow %
4.08%
Top 10 Hldgs %
23.82%
Holding
66
New
–
Increased
38
Reduced
10
Closed
9

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$3.35M
2
KVUE icon
Kenvue
KVUE
+$3.29M
3
RTO icon
Rentokil
RTO
+$3.21M
4
CME icon
CME Group
CME
+$2.96M
5
WMG icon
Warner Music
WMG
+$2.93M

Top Sells

Rank Stock Value
1
IFF icon
International Flavors & Fragrances
IFF
+$4.18M
2
MMM icon
3M
MMM
+$2.9M
3
OTIS icon
Otis Worldwide
OTIS
+$2.87M
4
HD icon
Home Depot
HD
+$2.76M
5
TRU icon
TransUnion
TRU
+$2.74M

Sector Composition

Rank Sector Weight
1 Healthcare 19.25%
2 Financials 17.09%
3 Consumer Staples 16.84%
4 Communication Services 16.06%
5 Technology 13.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
1
Berkshire Hathaway Class A
BRK.A
$1.11T
$17.3M 5.99%
23
– –
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.11T
$6.77M 2.34%
13,471
– –
EA icon
3
Electronic Arts
EA
$53B
$6.02M 2.08%
29,847
+650
+2% +$108K
EL icon
4
Estee Lauder
EL
$30.7B
$5.94M 2.05%
67,359
– –
PSBD icon
5
Palmer Square Capital BDC
PSBD
$306M
$5.66M 1.96%
461,609
– –
RTX icon
6
RTX Corp
RTX
$291B
$5.52M 1.91%
32,968
+377
+1% +$58.5K
AAPL icon
7
Apple
AAPL
$4.47T
$5.5M 1.9%
21,586
-54
-0.2% -$12.2K
GSK icon
8
GSK
GSK
$103B
$5.43M 1.88%
125,748
+64,746
+106% +$2.53M
JNJ icon
9
Johnson & Johnson
JNJ
$608B
$5.38M 1.86%
29,010
– –
FOX icon
10
Fox Class B
FOX
$21.9B
$5.37M 1.86%
93,767
+3,594
+4% +$190K
TMO icon
11
Thermo Fisher Scientific
TMO
$209B
$5.31M 1.83%
10,939
+176
+2% +$81.9K
GD icon
12
General Dynamics
GD
$104B
$5.28M 1.82%
15,481
-491
-3% -$155K
WMG icon
13
Warner Music
WMG
$13.3B
$5.23M 1.81%
153,443
+92,014
+150% +$2.93M
CHRW icon
14
C.H. Robinson
CHRW
$17.8B
$5.23M 1.81%
39,467
-7,000
-15% -$821K
NVO
15
Novo Nordisk
NVO
$211B
$5.16M 1.78%
93,006
+26,928
+41% +$1.58M
MDT icon
16
Medtronic
MDT
$110B
$5.16M 1.78%
54,158
+2,296
+4% +$211K
LYV icon
17
Live Nation Entertainment
LYV
$42.9B
$5.15M 1.78%
31,505
+14,377
+84% +$2.27M
TKO icon
18
TKO Group
TKO
$13.8B
$5.11M 1.77%
25,306
– –
NVS icon
19
Novartis
NVS
$293B
$5.08M 1.76%
39,628
+723
+2% +$88.2K
CME icon
20
CME Group
CME
$94.9B
$5.08M 1.75%
18,787
+10,894
+138% +$2.96M
WMT icon
21
Walmart Inc
WMT
$876B
$5.06M 1.75%
49,145
+3,135
+7% +$312K
RTO icon
22
Rentokil
RTO
$12.6B
$5.05M 1.75%
200,101
+131,826
+193% +$3.21M
ABT icon
23
Abbott
ABT
$183B
$5.05M 1.75%
37,722
+4,617
+14% +$606K
ACN icon
24
Accenture
ACN
$102B
$5.04M 1.74%
20,436
+6,106
+43% +$1.59M
EBAY icon
25
eBay
EBAY
$48.4B
$5.02M 1.74%
55,222
-4,304
-7% -$381K
1
2 3

Similar funds

JRCM
Jones Road Capital Management New York $55.3M AUM 29.97% 1-Year Est. Return
EI
Ecofi Investissements Nanterre, France $54.9M AUM 10.96% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $54.4M AUM
CAM
Copperwood Asset Management Houston, Texas $54.4M AUM
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Arlington Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arlington Partners held 66 positions worth $289M, up 6.8% from $271M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Arlington Partners deployed $11.8M of net new capital in Q3 2025, adding to 38 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Oracle, an estimated $2.14M trimmed.

  • Arlington Partners added most to Constellation Brands in Q3 2025, an estimated $3.35M increase.
  • Arlington Partners's biggest Q3 2025 reduction was Oracle, cutting an estimated $2.14M.
  • Arlington Partners fully exited International Flavors & Fragrances in Q3 2025, selling an estimated $4.18M.
  • Arlington Partners's ten largest holdings make up 24% of its $289M portfolio in Q3 2025.
  • Arlington Partners opened 0 new positions and closed 9 in Q3 2025.
  • Arlington Partners's portfolio value rose 6.8% quarter-over-quarter to $289M.

Based on Arlington Partners's 13F filing for Q3 2025, filed 28 Oct 2025.